Loss of beta2 microglobulin from the cell surface of cutaneous malignant and premalignant lesions

The British Journal of Dermatology
M L Turbitt, R M Mackie

Abstract

Biopsies from twenty-three patients with malignant skin lesions and from twenty-two patients with premalignant or benign skin lesions were stained for beta2 microglobulin by use of the immunoperoxidase technique. The results showed a significant loss of demonstrable surface beta2 microglobulin from the surface of malignant cells compared to benign, and a partial loss in the premalignant cases. This difference could prove to be a useful tool in the histological diagnosis of malignant skin lesions, and in assessing whether or not the lesion has been completely excised.

References

Nov 1, 1976·European Journal of Immunology·M Governa, S Biguzzi
Jan 1, 1974·Proceedings of the National Academy of Sciences of the United States of America·P A PetersonJ B Lindblom
Jan 1, 1974·Tissue Antigens·B G Solheim, E Thorsby
May 1, 1973·Proceedings of the National Academy of Sciences of the United States of America·P CresswellJ L Strominger

❮ Previous
Next ❯

Citations

Jan 1, 1988·Human Genetics·M Bar-EliM J Cline
Jan 1, 1988·Archives of Dermatological Research·M BradbeerR Marks
Nov 1, 1995·Clinics in Dermatology·A C Markey
Dec 1, 1981·Journal of the American Academy of Dermatology·M V Dahl
Feb 15, 2001·Journal of Hematotherapy & Stem Cell Research·S Agrawal, M C Kishore
Jul 1, 1993·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·B L PetersenO Werdelin
Oct 1, 1983·The Journal of Dermatology·M Furue, Y Inoue
Dec 1, 1983·The British Journal of Dermatology·T J HarristA K Bhan
May 1, 1986·Clinical and Experimental Dermatology·J A BirkinL G Millard
Sep 1, 1983·Clinical and Experimental Dermatology·C A Holden, D M MacDonald
Dec 1, 1985·International Journal of Dermatology·L A HuaR W Goltz
Sep 1, 1985·European Journal of Cancer & Clinical Oncology·S E ThomasR Marks
Feb 1, 1983·Journal of Cutaneous Pathology·J Thivolet, M Faure
Apr 1, 1990·Journal of Cutaneous Pathology·A C MarkeyD M MacDonald
Jun 1, 1991·Journal of Cutaneous Pathology·M H AllenD M MacDonald
Oct 1, 1987·The British Journal of Dermatology·R M GrahamJ R Nash
Jul 15, 1987·International Journal of Cancer. Journal International Du Cancer·P MöllerF Momburg
Nov 1, 1982·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology·N Graem
Dec 1, 1986·The Journal of Urology·G R WaltonS D Graham
Apr 1, 1986·Journal of Immunogenetics·F MomburgG J Hämmerling
Feb 15, 1986·International Journal of Cancer. Journal International Du Cancer·F MomburgP Möller
Jul 1, 1983·Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Section A, Pathology·M Kallioinen, K Dammert
May 1, 1985·Journal of Surgical Oncology·D P SarmaL E Millikan
Feb 5, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Apostolia-Maria TsimberidouElihu H Estey
Aug 1, 1994·Critical Reviews in Oncology/hematology·G V Glinsky

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.